Featured Research

from universities, journals, and other organizations

New tick-borne disease threatens primarily immune suppressed persons

Date:
May 27, 2014
Source:
University of Gothenburg
Summary:
A newly discovered tick-borne bacterium known as "Candidatus Neoehrlichia mikurensis" has been implicated in six cases of disease in Sweden. A new international study has shown that this bacterium is primarily a risk for people who are already sick and who are receiving immunosuppressive drugs.

A newly discovered tick-borne bacterium known as "Candidatus Neoehrlichia mikurensis" has been implicated in six cases of disease in Sweden. A new international study led by the Sahlgrenska Academy, University of Gothenburg, has shown that this bacterium is primarily a risk for people who are already sick and who are receiving immunosuppressive drugs.

The Candidatus Neoehrlichia mikurensis bacterium, known in the medical world by its short name Neoehrlichia, was discovered and described for the first time in a scientific article in 2010.

The bacterium, which is spread by rodents and ticks mainly in Asia and Europe, including Sweden, has been found in 19 cases worldwide, six of them in Sweden.

Eleven cases closely examined

Scientists and doctors from Germany, Switzerland, The Czech Republic and Sweden have examined 11 of these cases more closely, in an international research project led by the Sahlgrenska Academy. The study has shown that it is primarily people who are already sick who run the greatest risk of becoming infected by the bacterium.

"Those who run the greatest risk are generally over the age of 50 years, suffer either from a haematological disease or a rheumatic disease, and are currently undergoing immunosuppressive treatment with, for example, chemotherapy or cortisone," says Christine Wennerεs, scientist at the University of Gothenburg.

Difficult to detect

No figures are available for how common the tick-borne infection, neoehrlichiosis is in humans. This is mainly due to the infection being difficult to detect.

"The bacterium cannot be grown in culture, and this means that it is not picked up in routine diagnostic procedures. Furthermore, the symptoms are deceptive: several patients, for example, have been affected by blood clots in the leg or the blood vessels in the head, and this has not been coupled to an infectious cause. Other typical symptom such as fever, muscle pain and joint pain can be caused also by the patient's underlying disease," says Christine Wennerεs.

"We know very little about how the infection affects otherwise healthy people who are not taking immunosuppressive drugs."

Once neoehrlichiosis has been diagnosed, the patients recover completely after treatment with antibiotics.


Story Source:

The above story is based on materials provided by University of Gothenburg. Note: Materials may be edited for content and length.


Journal Reference:

  1. A. Grankvist, P.-O. Andersson, M. Mattsson, M. Sender, K. Vaht, L. Hoper, E. Sakiniene, E. Trysberg, M. Stenson, J. Fehr, S. Pekova, C. Bogdan, G. Bloemberg, C. Wenneras. Infections With the Tick-Borne Bacterium "Candidatus Neoehrlichia mikurensis" Mimic Noninfectious Conditions in Patients With B Cell Malignancies or Autoimmune Diseases. Clinical Infectious Diseases, 2014; 58 (12): 1716 DOI: 10.1093/cid/ciu189

Cite This Page:

University of Gothenburg. "New tick-borne disease threatens primarily immune suppressed persons." ScienceDaily. ScienceDaily, 27 May 2014. <www.sciencedaily.com/releases/2014/05/140527114503.htm>.
University of Gothenburg. (2014, May 27). New tick-borne disease threatens primarily immune suppressed persons. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2014/05/140527114503.htm
University of Gothenburg. "New tick-borne disease threatens primarily immune suppressed persons." ScienceDaily. www.sciencedaily.com/releases/2014/05/140527114503.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) — The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) — Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) — America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) — A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:  

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile iPhone Android Web
          Follow Facebook Twitter Google+
          Subscribe RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins